-+ 0.00%
-+ 0.00%
-+ 0.00%

National Medical Products Administration In China Grants ARS Pharmaceuticals Approval For Neffy 2 mg For Emergency Treatment Of Type 1 Allergic Reactions In Adults And Children Who Weigh 30+ KG.

Benzinga·12/29/2025 13:05:37
Listen to the news

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions

Pediatrix Therapeutics, which has a license from ARS Pharma to market neffy in China under the trade name 优敏速®, expects availability in the spring of 2026